CAS 496808-04-9 1-((1-Methyl-4-piperidinyl)methyl)piperazine (HCID 2736942)

기본 정보

CAS: 496808-04-9
표준 SMILES: CN1CCC(CN2CCNCC2)CC1
InChIKey: VGEQUMWEQWWIJT-UHFFFAOYSA-N
분자식: C11H23N3
평균 분자량: 197.32 g/mol
단동위원소 질량: 197.18919774

이름 및 식별자

우선 이름: 1-((1-Methyl-4-piperidinyl)methyl)piperazine
IUPAC: 1-[(1-methylpiperidin-4-yl)methyl]piperazine
현지명: 1-(N-메틸피페리딘-4-일-메틸)피페라진
영어명: 1-(N-METHYLPIPERIDIN-4-YL-METHYL)PIPERAZINE
분자식: C11H23N3
분자량: 197.32

이름 및 동의어

496808-04-91-((1-Methyl-4-piperidinyl)methyl)piperazine1-[(1-methyl-4-piperidinyl)methyl]piperazineRefChem:2219821-[(1-methylpiperidin-4-yl)methyl]piperazine1-((1-methylpiperidin-4-yl)methyl)piperazine1-(N-Methylpiperidin-4-yl-methyl)piperazineMFCD020935391-(1-methyl-piperidin-4-yl-methyl)-piperazinePiperazine, 1-[(1-methyl-4-piperidinyl)methyl]-RARECHEM AH CK 01411-[(1-methyl-4-piperidyl)methyl]piperazine

이름 더 보기

1-(N-메틸피페리딘-4-일-메틸)피페라진1-(1-Methyl-piperidin-4-yl-methyl)-1-(N-METHYL-4-PIPERIDINYLMETHYL)PIPERAZINE1-Methyl-4-[(piperazin-1-yl)methyl]piperidine1-(1-METHYL-PIPERIDIN-4-YL-METHYL)-PIPERAZINE >98%

4-[(1-methyl-4-piperidinyl)methyl]piperazineSCHEMBL945557SCHEMBL1264162DTXSID80371720VGEQUMWEQWWIJT-UHFFFAOYSA-NAKOS0091585971-[1-(4-piperidinyl)ethyl]piperazinePS-5069

데이터베이스 식별자

CAS: 496808-04-9
PubChem CID: 2736942
DTXSID: DTXSID80371720
EC Number: 671-456-1

물성

구조 계산 물성

XLogP: 0.4
극성 표면적: 18.5 Å²
수소 결합 공여자 수: 1
수소 결합 수용자 수: 3
회전 가능 결합 수: 2
무거운 원자 수: 14
형식 전하: 0
복잡도: 158

물리화학적 성질

끓는 점: 76 °C · 76 °C
물리적 상태: 액체
색상: 무색

안전 및 규제

GHS 분류

GHS Classification · 4건

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.